Royalty Pharma plc
Royalty Pharma plc (RPRX) Wheel Strategy
RPRX wheel strategy scan found 9 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 29.5%.
Read more
Running a RPRX wheel strategy lets you generate consistent premium income on Royalty Pharma plc while setting your own entry and exit prices on the underlying. Royalty Pharma plc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own RPRX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best RPRX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on RPRX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable RPRX wheel from a losing one.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes.
The company was founded in 1996 and is based in New York, New York.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the RPRX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your RPRX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 57.50 | $0.30 | $2.60 | -0.42 | 56 | 23% | 53.8% | 29.5% | 3 |
| Oct 16, 2026 | 55.00 | $0.15 | $0.85 | -0.25 | 21 | 23% | 78.1% | 26.9% | 19 |
| Dec 18, 2026 | 47.50 | $0.10 | $2.50 | -0.20 | 84 | 23% | 91.6% | 22.9% | 73 |
| Dec 18, 2026 | 57.50 | $0.50 | $2.70 | -0.41 | 84 | 23% | 53.0% | 20.4% | 5 |
| Jan 15, 2027 | 57.50 | $0.70 | $2.80 | -0.41 | 112 | 23% | 52.5% | 15.9% | 3 |
| Jan 15, 2027 | 55.00 | $0.30 | $2.60 | -0.32 | 112 | 23% | 62.7% | 15.4% | 3 |
| Apr 16, 2027 | 57.50 | $1.15 | $3.58 | -0.39 | 203 | 23% | 51.6% | 11.2% | 0 |
| Apr 16, 2027 | 55.00 | $0.50 | $2.70 | -0.31 | 203 | 23% | 59.3% | 8.8% | 0 |
| Apr 16, 2027 | 52.50 | $0.10 | $2.50 | -0.26 | 203 | 23% | 67.0% | 8.6% | 0 |
As of September 25, 2026
Run the Wheel on RPRX With Confidence
Find the best RPRX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→